Core Viewpoint - The announcement details a significant ownership change in Chengzhi Co., with the indirect controlling shareholder, Qingdao Haikong Investment Holdings Co., transferring 100% of its shares in Chengzhi to its wholly-owned subsidiary, Dongjiakou Group, which will indirectly acquire 30.83% of Chengzhi's shares [1][2]. Group 1: Ownership Change - Dongjiakou Group has signed an agreement to acquire 100% of Qingdao Haikong Investment Holdings Co. without any monetary compensation, only incurring necessary fees as per national regulations [2]. - Prior to this acquisition, Dongjiakou Group did not hold any shares in Chengzhi, while Chengzhi Kairong, the current controlling shareholder, holds 375 million shares, representing 30.83% of the total share capital [1][2]. Group 2: Business Operations - Chengzhi Co. operates in industrial gases, basic chemical raw materials, semiconductor display materials, life science products, and industrial hemp cultivation and processing [2]. - The company reported a revenue of 11.066 billion yuan and a net profit of 231 million yuan for the fiscal year 2024, marking a year-on-year increase of 29.98% [2]. Group 3: Strategic Integration - The acquisition aims to promote internal strategic integration within Haikong Group, transferring ownership of Haikong Investment Holdings to Dongjiakou Group [1][2]. - There is no indication of competitive conflict between the businesses of the acquirer and Chengzhi, ensuring no adverse effects on the company's operations or minority shareholders [3].

Core Viewpoint - The collaboration between Chengzhi Co., various research institutions, and universities in Yunnan focuses on the development and utilization of biodiversity and industrial hemp, aiming to integrate resources for comprehensive industry chain development [2][12]. Group 1: Collaboration Details - Chengzhi Co. signed cooperation agreements with multiple institutions, including Tsinghua University and Yunnan Agricultural Academy, to enhance industrial hemp development [1]. - The partnership aims to create a full-chain collaboration from breeding and planting to basic research, application development, and industrial transformation [2][6]. - The initiative will leverage the strengths of universities and research institutions to overcome technical bottlenecks in the industrial hemp industry [2][12]. Group 2: Research and Development Focus - Chengzhi Hanmeng Pharmaceutical will focus on key technologies such as improving CBD yield and constructing a closed-loop system for THC destruction [4]. - The collaboration will explore high-value utilization paths for agricultural waste, particularly focusing on industrial hemp stalks [5]. - Research will include the comprehensive utilization of various parts of the industrial hemp plant, establishing a full-chain system from cultivation to market application [6]. Group 3: Educational and Employment Initiatives - The partnership will establish employment and innovation practice bases to provide practical platforms for students and supply high-quality talent to enterprises [8]. - The collaboration aims to create a model for innovation cooperation between higher education institutions and industry, promoting synergy in education and research [10]. Group 4: Future Development Goals - The focus will be on technological innovation across the entire industrial hemp chain, developing high-value products, and exploring new applications in pharmaceuticals, health care, and daily chemicals [12]. - Chengzhi Co. plans to deepen cooperation with various parties to explore high-value development paths for Yunnan's unique biological resources, contributing to the high-quality development of the local bio-industry [15].